Nxera Pharma and MODEC Report Earnings, Reaffirm FY 2026 Outlook

Nxera Pharma reported GAAP EPS of ¥15.86 and revenue of ¥18.91B, while MODEC, Inc. reported GAAP EPS of $3.28 and revenue of $2.45B. Both companies reaffirmed their financial outlook for fiscal year 2026.